Skip to main content

Cisatracurium

NDC 63323-418 · Fresenius Kabi USA, LLC

Generic nameCISATRACURIUM BESYLATE
Dosage formINJECTION, SOLUTION
RouteINTRAVENOUS
Active ingredient(s)CISATRACURIUM BESYLATE
Strength10 mg/mL
Pharmacologic classNeuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]
Marketing categoryANDA

Packages

63323-418-20 — 10 VIAL in 1 CARTON (63323-418-20) / 20 mL in 1 VIAL (63323-418-01)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0781-3150 — cisatracurium besylate, 0781-3152 — cisatracurium besylate, 0781-3153 — cisatracurium besylate, 31722-312 — Cisatracurium Besylate, 31722-313 — Cisatracurium Besylate, 31722-314 — Cisatracurium Besylate, 55150-284 — Cisatracurium Besylate, 55150-286 — Cisatracurium Besylate, 63323-416 — CISATRACURIUM BESYLATE, 63323-417 — CISATRACURIUM BESYLATE, 65145-135 — Cisatracurium besylate, 65145-136 — Cisatracurium besylate, 65145-137 — Cisatracurium besylate, 68083-486 — Cisatracurium besylate, 68083-487 — Cisatracurium besylate, 68083-488 — Cisatracurium besylate, 70069-141 — Cisatracurium Besylate, 70069-151 — Cisatracurium Besylate, 70069-161 — Cisatracurium Besylate, 70436-112 — Cisatracurium besylate, +17 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.